http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-8403897-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
filingDate 1984-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8c952c2a8c29e2a06c8e61480fa9f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0aea4c9c2e28ee1ba19077f5dfcff8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976571a38d350cdb5f8889893e396e2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de255dae94cd55ce372c88a2a5fe72aa
publicationDate 1985-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-8403897-L
titleOfInvention CEPHALOSPORINS
abstract A process for obtaining highly pure crystalline cefuroxime axetil comprises crystallising cefuroxime axetil from a solution thereof in an organic or aqueous solvent or a mixture thereof and then drying and isolating the product. Preferred solvents are alkyl acetates in admixture with ethers or aliphatic or aromatic hydrocarbons. The higher the yield from crystallisation, the closer to a 1:1 stoichiometric ratio of R:S isomers the product will contain, this being most desirable for an antibiotic product which is to be administered orally.
priorityDate 1983-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID52921562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421670804

Total number of triples: 29.